In vivo models have been performed in nude and Balb/C mice, in which the expression of syntenin-1 can fluctuate according to the type of cancer; also, the effectivity of the evaluated treatment cannot be reached in humans due to differences in the metabolism, the type/stage of cancer or physiological factors of the host. The gene discussed is SDCBP; the disease is cancer.